knowledge -WSS

knowledge

author：Wikipedia 2025-09-29 19:58:46 - browse：233

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： FDA cancer chief on how to get things done: ‘Don’t tell anybody'

entertainment

WSS

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Lecanemab for Alzheimer's is coming. Is the health system ready?

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

How the political right came to back psychedelics to treat trauma

explore

knowledge

hotspot

Drug repurposing or repositioning? The language matters

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What to know about OceanGate, the company behind the missing Titanic submersible

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Iowa House, Senate pass 6

BioMarin wins approval for gene therapy to treat hemophilia A

N.Y. state detects polio case, first in the U.S. since 2013

Trump demands the U.S. pay no more for drugs than other countries … again

N.Y. state detects polio case, first in the U.S. since 2013

leisure time

Iowa House, Senate pass 6

Elizabeth Holmes on track for early release from her 11

Ventyx halts psoriasis drug development after lackluster trial results

Medical school prerequisites are outdated

Readout Newsletter: Zepbound, Valneva's vaccine, and more

What health policies could hitch a ride on a spending bill?

entertainment

hotspot

hotspot

entertainment